Consolidated Statement Of Profit Or Loss

ONO PHARMACEUTICAL CO., LTD. - Filing #7595379

Concept	2022-04-01 to 2022-06-30	2022-04-01 to 2022-06-30	2022-04-01 to 2022-06-30	2022-04-01 to 2022-06-30	2021-04-01 to 2021-06-30	2021-04-01 to 2021-06-30	2021-04-01 to 2021-06-30	2021-04-01 to 2021-06-30
Consolidated statement of profit or loss
Statement of profit or loss
Revenue	—	—	106,722,000,000 JPY	—	—	—	—	87,363,000,000 JPY
Cost of sales	—	—	26,937,000,000 JPY	—	—	—	—	22,799,000,000 JPY
Gross profit	—	—	79,785,000,000 JPY	—	—	—	—	64,564,000,000 JPY
Selling, general and administrative expenses	—	—	21,726,000,000 JPY	—	—	—	—	18,955,000,000 JPY
Other income	—	—	106,000,000 JPY	—	—	—	—	188,000,000 JPY
Other expenses	—	—	590,000,000 JPY	—	—	—	—	760,000,000 JPY
Operating profit (loss)	—	—	38,162,000,000 JPY	—	—	—	—	29,792,000,000 JPY
Finance income	—	—	1,159,000,000 JPY	—	—	—	—	1,316,000,000 JPY
Finance costs	—	—	279,000,000 JPY	—	—	—	—	303,000,000 JPY
Share of profit (loss) of investments accounted for using equity method	—	—	0 JPY	—	—	—	—	-1,000,000 JPY
Profit (loss) before tax	—	—	39,041,000,000 JPY	—	—	—	—	30,804,000,000 JPY
Income tax expense	—	—	9,513,000,000 JPY	—	—	—	—	6,697,000,000 JPY
Profit (loss)	29,477,000,000 JPY	29,477,000,000 JPY	29,528,000,000 JPY	51,000,000 JPY	24,074,000,000 JPY	24,074,000,000 JPY	34,000,000 JPY	24,108,000,000 JPY
Profit (loss) attributable to
Owners of parent	—	—	29,477,000,000 JPY	—	—	—	—	24,074,000,000 JPY
Non-controlling interests	—	—	51,000,000 JPY	—	—	—	—	34,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share	—	—	60.37	—	—	—	—	48.23
Diluted earnings (loss) per share	—	—	60.36	—	—	—	—	48.22